Late multiple organ surge in interferon-regulated target genes characterizes staphylococcal enterotoxin B lethality.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 3923834)

Published in PLoS One on February 13, 2014

Authors

Gabriela A Ferreyra1, Jason M Elinoff1, Cumhur Y Demirkale2, Matthew F Starost3, Marilyn Buckley4, Peter J Munson2, Teresa Krakauer4, Robert L Danner1

Author Affiliations

1: Functional Genomics and Proteomics Facility, Critical Care Medicine Department, Clinical Research Center, National Institutes of Health, Bethesda, Maryland, United States of America.
2: Mathematical and Statistical Computing Laboratory, Center for Information Technology, National Institutes of Health, Bethesda, Maryland, United States of America.
3: Division of Veterinary Resources, Office of Research Services, National Institutes of Health, Bethesda, Maryland, United States of America.
4: Integrated Toxicology Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, United States of America.

Articles cited by this

STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res (2012) 18.26

RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science (2006) 16.00

DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature (2007) 13.56

The staphylococcal enterotoxins and their relatives. Science (1990) 11.99

Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature (2010) 11.24

Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity (2006) 10.61

Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med (1989) 8.01

Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med (1980) 7.85

Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc Natl Acad Sci U S A (1989) 7.48

HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature (2011) 5.28

Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol (2001) 4.48

Type I interferon: friend or foe? J Exp Med (2010) 4.40

Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev (2006) 4.13

Endotoxemia in human septic shock. Chest (1991) 3.52

The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat Immunol (2002) 3.45

Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway. Nat Immunol (2008) 3.43

Gram-positive toxic shock syndromes. Lancet Infect Dis (2009) 3.37

Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules. Proc Natl Acad Sci U S A (2008) 3.27

Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci U S A (2004) 3.16

Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. Am J Respir Crit Care Med (2002) 2.95

Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet (1986) 2.69

Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis (1999) 2.69

Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis (2003) 2.54

Toll-like receptor-dependent and -independent viperin gene expression and counter-regulation by PRDI-binding factor-1/BLIMP1. J Biol Chem (2006) 2.40

Binding of staphylococcal enterotoxin A to accessory cells is a requirement for its ability to activate human T cells. J Immunol (1988) 2.28

Interferome v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res (2012) 2.08

The multiple facets of mTOR in immunity. Trends Immunol (2009) 1.89

TRIM79α, an interferon-stimulated gene product, restricts tick-borne encephalitis virus replication by degrading the viral RNA polymerase. Cell Host Microbe (2011) 1.84

Staphylococcus aureus activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein A. J Clin Invest (2009) 1.77

Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: major histocompatibility complex class II molecule dependency and cytokine release. Infect Immun (1993) 1.69

Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses. J Exp Med (1993) 1.66

Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFNgamma-mediated signaling. Cell (1999) 1.64

The multifunctional role of mTOR in innate immunity: implications for transplant immunity. Am J Transplant (2009) 1.60

The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases. Cell Mol Immunol (2006) 1.54

An enterotoxin-like protein in Staphylococcus aureus strains from patients with toxic shock syndrome. Ann Intern Med (1982) 1.48

Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells. Eur J Immunol (2008) 1.46

Toxins as weapons of mass destruction. A comparison and contrast with biological-warfare and chemical-warfare agents. Clin Lab Med (2001) 1.46

Staphylococcal toxic shock syndrome 2000-2006: epidemiology, clinical features, and molecular characteristics. PLoS One (2011) 1.43

Superantigens: biology, immunology, and potential role in disease. J Clin Immunol (1992) 1.38

CD28 and T cell antigen receptor signal transduction coordinately regulate interleukin 2 gene expression in response to superantigen stimulation. J Exp Med (1992) 1.36

Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon response. J Exp Med (2012) 1.36

DNA makes RNA makes innate immunity. Cell (2009) 1.34

The 2-5A system in viral infection and apoptosis. Biomed Pharmacother (1998) 1.30

Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome. J Infect Dis (1999) 1.30

Selective potentiation of Stat-dependent gene expression by collaborator of Stat6 (CoaSt6), a transcriptional cofactor. Proc Natl Acad Sci U S A (2006) 1.29

Type I interferon drives tumor necrosis factor-induced lethal shock. J Exp Med (2009) 1.25

Immune response to staphylococcal superantigens. Immunol Res (1999) 1.23

Hepatic injury and lethal shock in galactosamine-sensitized mice induced by the superantigen staphylococcal enterotoxin B. Gastroenterology (1994) 1.18

Application of housekeeping npcRNAs for quantitative expression analysis of human transcriptome by real-time PCR. RNA (2009) 1.17

PARP-14 functions as a transcriptional switch for Stat6-dependent gene activation. J Biol Chem (2010) 1.14

Comparative analysis of lipopolysaccharide-induced tumor necrosis factor alpha activity in serum and lethality in mice and rabbits pretreated with the staphylococcal superantigen toxic shock syndrome toxin 1. Infect Immun (2001) 1.14

Correlation between serum TNF alpha and IL6 levels and severity of group A streptococcal infections. Scand J Infect Dis (1995) 1.12

The interferon signaling network and transcription factor C/EBP-beta. Cell Mol Immunol (2007) 1.12

Aerosolized staphylococcal enterotoxin B-induced pulmonary lesions in rhesus monkeys (Macaca mulatta). Toxicol Pathol (1995) 1.11

Superantigen shock in mice with an inapparent viral infection. J Infect Dis (1994) 1.08

PARP-14, a member of the B aggressive lymphoma family, transduces survival signals in primary B cells. Blood (2009) 1.08

An extended set of PRDM1/BLIMP1 target genes links binding motif type to dynamic repression. Nucleic Acids Res (2010) 1.07

Human leukocyte antigen-DQ8 transgenic mice: a model to examine the toxicity of aerosolized staphylococcal enterotoxin B. Infect Immun (2005) 1.06

Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice. Infect Immun (2006) 1.05

Maturation of human dendritic cells is accompanied by functional remodelling of the ubiquitin-proteasome system. Int J Biochem Cell Biol (2008) 1.04

Regulation of interferon production by RIG-I and LGP2: a lesson in self-control. Sci STKE (2007) 0.99

One in five mortality in non-menstrual toxic shock syndrome versus no mortality in menstrual cases in a balanced French series of 55 cases. Eur J Clin Microbiol Infect Dis (2008) 0.98

The toxic shock syndromes. Infect Dis Clin North Am (1996) 0.98

Costimulatory receptors for the superantigen staphylococcal enterotoxin B on human vascular endothelial cells and T cells. J Leukoc Biol (1994) 0.97

Increased susceptibility to staphylococcal enterotoxin B intoxication in mice primed with actinomycin D. Infect Immun (1994) 0.97

New PARP gene with an anti-alphavirus function. J Virol (2012) 0.97

HERC6 is the main E3 ligase for global ISG15 conjugation in mouse cells. PLoS One (2012) 0.96

Cardiovascular inflammation and lesion cell apoptosis: a novel connection via the interferon-inducible immunoproteasome. Arterioscler Thromb Vasc Biol (2009) 0.95

Poly(ADP-ribose) regulates post-transcriptional gene regulation in the cytoplasm. RNA Biol (2012) 0.94

Chronic exposure to staphylococcal superantigen elicits a systemic inflammatory disease mimicking lupus. J Immunol (2012) 0.94

Interferon gamma-dependent intestinal pathology contributes to the lethality in bacterial superantigen-induced toxic shock syndrome. PLoS One (2011) 0.92

Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury. Arthritis Rheum (2004) 0.91

Rapamycin protects mice from staphylococcal enterotoxin B-induced toxic shock and blocks cytokine release in vitro and in vivo. Antimicrob Agents Chemother (2010) 0.90

The macroPARP genes Parp-9 and Parp-14 are developmentally and differentially regulated in mouse tissues. Dev Dyn (2008) 0.90

Central roles for IL-2 and MCP-1 following intranasal exposure to SEB: a new mouse model. Res Vet Sci (2008) 0.89

Cellular and cytokine responses in the circulation and tissue reactions in the lung of rhesus monkeys (Macaca mulatta) pretreated with cyclosporin A and challenged with staphylococcal enterotoxin B. Toxicol Pathol (2001) 0.85

Therapeutic down-modulators of staphylococcal superantigen-induced inflammation and toxic shock. Toxins (Basel) (2010) 0.85

Murine lethal toxic shock caused by intranasal administration of staphylococcal enterotoxin B. Toxicol Pathol (2003) 0.84

Critical timing, location and duration of glucocorticoid administration rescue mice from superantigen-induced shock and attenuate lung injury. Int Immunopharmacol (2009) 0.84

Staphylococcal enterotoxin B in vivo modulates both gamma interferon receptor expression and ligand-induced activation of signal transducer and activator of transcription 1 in T cells. Infect Immun (2006) 0.80

Cytokine profile during the clinical course of toxic shock syndrome. Clin Exp Dermatol (2009) 0.79

Comparison of hemodynamic changes resulting from toxic shock syndrome toxin-1-producing Staphylococcus aureus sepsis and endotoxin-producing gram-negative rod sepsis in patients with severe burns. J Burn Care Rehabil (1996) 0.76

The viral enterprises in autoimmunity: conversion of target cells into de novo APCs is the presage to autoimmunity. Autoimmun Rev (2011) 0.76